←
LSI - Life Science Intelligence™4,146 posts
LSI - Life Science Intelligence™ avatar

LSI - Life Science Intelligence™

@lsintelligence

We help Medtech leaders access the community, capital, and insights that enable growth. Join us at our next event → LSI USA '27 March 15-19 in Dana Point

◷ Joined April 2009▧ 2,555 Photos and videos
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·8 Oct 2025

Amira Romani’s full keynote from LSI Europe ‘25 is now available. Amira Romani is Head of Innovation Strategy at @SiemensHealth and leads the global innovation ecosystem Siemens Healthineers SHIFT. In this role, she drives international collaboration with partners from research, industry, start-ups, and policy on key topics such as digital transformation, sustainability, and health equity. She also initiates and supports strategic consortium projects—such as improving stroke care in Europe—to foster impactful innovation in healthcare. This session was moderated by Joe Mullings, Chairman & CEO of @MullingsGroup. Watch the full session now on our website and YouTube channel.

1:30
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·8 Oct 2025

RevBio (#LSIAlumni) announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). This two-year grant builds upon the work that was completed in a prior Phase I grant and will enable the company to complete preclinical product testing which is a key development step for obtaining approval from the FDA to initiate a human clinical trial. Congratulations to Founder and CEO Brian Hess and the entire @RevBio_ team on another major milestone!

Post attachment
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·8 Oct 2025

Neuronoff (#LSIAlumni) announced the closure of an oversubscribed $4.5 million financing round to advance its Injectrode® platform toward FDA clearance and commercial launch. The funding supports scaling production to 1,000 units annually and preparing for a limited U.S. launch in 2026 targeting interventional pain physicians, spinal surgeons, podiatrists, and other specialties treating chronic pain. Congratulations to CEO Manfred Franke and the entire @Neuronoff team on this successful raise!

Post attachment
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·8 Oct 2025

Amira Romani’s full keynote from LSI Europe ‘25 is now available. Amira Romani is Head of Innovation Strategy at @SiemensHealth and leads the global innovation ecosystem Siemens Healthineers SHIFT. In this role, she drives international collaboration with partners from research, industry, start-ups, and policy on key topics such as digital transformation, sustainability, and health equity. She also initiates and supports strategic consortium projects—such as improving stroke care in Europe—to foster impactful innovation in healthcare. This session was moderated by @joemullings, Chairman & CEO of @MullingsGroup. Watch the full session now.

40:51
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·7 Oct 2025

How can companies ensure their evidence strategy supports their path to market? In this clip, Shai Ran Sapir highlights why both clinical and market evidence are essential to a company’s success. Generating strong clinical data is only part of the equation. Companies must also prove there’s a real market and that the problem they’re solving truly exists. Watch the full session “Integrated Evidence Planning: Building a Roadmap for Development and Commercial Success”, now available on our website and YouTube, featuring: - Joseph Ferrara — Chief Strategy Officer, @VeranexSolution - Laurent Pacheco — Venture Partner, @SolasBio - Bill Niland — CEO, ReGelTec - Erin McEachren — Vice President & General Manager, Enabling Technologies: Cranial and Spinal Technologies, @Medtronic - Pablo Morales — Former FDA - Shai Ran Sapir — Technology Development Manager - Cardiovascular Lead, @MayoClinic #LSIEurope25

2:26
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·7 Oct 2025

Dova Health Intelligence Inc. (#LSIAlumni)announced a collaboration with Mayo Clinic to advance the development and validation of its DovaVision UC Mayo Endoscopic Score (MES), an artificial intelligence tool designed for more precise and reproducible scoring of ulcerative colitis disease activity from colonoscopy videos. Congratulations to CEO Solveig Johannessen, and the entire team on this collaboration! thenewswire.com/press-releas…

LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·7 Oct 2025

Xenocor (#LSIAlumni) has announced the issuance of U.S. Patent No. 12,429,685 B2 for its innovative medical borescope and tip assembly technology. The newly granted patent covers a range of novel features, including the integration of electromagnetic interference (EMI) shielding within the Saberscope® tip assembly. Congratulations to LSI Alumni and COO, Tony Watson, and the entire Xenocor team! prnewswire.com/news-releases…

Post attachment
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·7 Oct 2025

New LSI Europe ‘25 panel released — Integrated Evidence Planning: Building a Roadmap for Development and Commercial Success This panel explored how companies can design evidence strategies that support both product approval and market adoption. With perspectives from strategy, investment, clinical development, regulation, and commercialization, the discussion highlighted what it takes to align stakeholders and build a roadmap that drives long-term success. This session featured: - Joseph Ferrara — Chief Strategy Officer, @VeranexSolution - Laurent Pacheco — Venture Partner, @SolasBio - Bill Niland — CEO, ReGelTec - Erin McEachren — Vice President & General Manager, Enabling Technologies: Cranial and Spinal Technologies, @Medtronic - Pablo Morales — Former FDA - Shai Ran Sapir — Technology Development Manager - Cardiovascular Lead, @MayoClinic Watch the full LSI Europe ‘25 session, now available.

37:33
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·6 Oct 2025

AtaCor Medical (#LSIAlumni) has secured financing of up to $75 million. The proceeds will fund the company's U.S. FDA Pivotal Study evaluating AtaCor's parasternal extravascular implantable cardioverter-defibrillator (EV-ICD) system for the treatment of life-threatening ventricular tachyarrhythmias. Congratulations to CEO Rick Sanghera, and the entire @AtaCorMedical team on this new financing!

Post attachment
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·6 Oct 2025

What inspired @HarryStebbings to launch @20vcFund? Driven by his passion for technology, finance, and venture, Harry Stebbings started 20VC from his bedroom at just 18 years old. His journey was also deeply personal. After his mother was diagnosed with multiple sclerosis, he set out to raise $2 million in a single weekend to help cover the cost of her treatment. Hear Harry share the full story, and much more, in his Signature Series from LSI Europe ‘25, now available on our website and YouTube channel. Thank you, Harry, for sharing your story and helping us close out the final day of LSI Europe ‘25 with your insights on venture and the entrepreneurs shaping the future.

2:01
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·6 Oct 2025

MediView XR (#LSIAlumni) announced the close of its $24 million Series A funding round led by GE HealthCare. The round also included investment from Cleveland Clinic, Mayo Clinic, Edge Ventures, the investment arm of Emplify Health, and JobsOhio Growth Capital Fund. Congratulations to CEO & President, Mina Fahim, and the entire @MediViewXR team on the successful Series A raise!

Post attachment
LSI - Life Science Intelligence™ avatar
LSI - Life Science Intelligence™@lsintelligence·6 Oct 2025

Oath Surgical (@OathSurgical) announced an oversubscribed $24M Series A led by FPV Ventures. This round also included participation from McKesson Ventures and existing investors OSE, Black Opal Ventures, Tau Ventures, and Rogue VC, bringing total funding to $35M. Congratulations to LSI Alumni Dr. Oliver Keown, Founder and CEO of Oath Surgical, and the entire team on a successful Series A! Read more about Oath Surgical in The Memo, released earlier this year: lifesciencemarketresearch.co…

Post attachmentPost attachment